{"id":"https://openalex.org/W2165705156","doi":"https://doi.org/10.1093/jac/dkq184","title":"Flucloxacillin dosing in critically ill patients with hypoalbuminaemia: special emphasis on unbound pharmacokinetics","display_name":"Flucloxacillin dosing in critically ill patients with hypoalbuminaemia: special emphasis on unbound pharmacokinetics","alternate_titles":[],"publication_year":2010,"publication_date":"2010-06-08","ids":{"openalex":"https://openalex.org/W2165705156","doi":"https://doi.org/10.1093/jac/dkq184","mag":"2165705156","pmid":"https://pubmed.ncbi.nlm.nih.gov/20530507"},"language":"en","primary_location":{"id":"doi:10.1093/jac/dkq184","doi":"https://doi.org/10.1093/jac/dkq184","is_oa":false,"landing_page_url":"https://doi.org/10.1093/jac/dkq184","pdf_url":null,"source":{"id":"https://openalex.org/S124275759","display_name":"Journal of Antimicrobial Chemotherapy","issn_l":"0305-7453","issn":["0305-7453","1460-2091"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Antimicrobial Chemotherapy","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2165705156"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5090012662","display_name":"Marta Ulldemolins","orcid":"https://orcid.org/0000-0002-5050-8430","observed_orcids":["https://orcid.org/0000-0002-5050-8430"]},"institutions":[{"id":"https://openalex.org/I123044942","display_name":"Universitat Aut\u00f2noma de Barcelona","ror":"https://ror.org/052g8jq94","country_code":"ES","type":"education","lineage":["https://openalex.org/I123044942"]},{"id":"https://openalex.org/I165143802","display_name":"The University of Queensland","ror":"https://ror.org/00rqy9422","country_code":"AU","type":"education","lineage":["https://openalex.org/I165143802"]},{"id":"https://openalex.org/I4210099160","display_name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Respiratorias","ror":"https://ror.org/0119pby33","country_code":"ES","type":"facility","lineage":["https://openalex.org/I2801357902","https://openalex.org/I4210099160","https://openalex.org/I4210115082","https://openalex.org/I4387152914"]},{"id":"https://openalex.org/I4210101772","display_name":"Institut de Recerca Biom\u00e8dica Catalunya Sud","ror":"https://ror.org/01av3a615","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210101772","https://openalex.org/I4387153040"]},{"id":"https://openalex.org/I4210102407","display_name":"Vall d'Hebron Institut de Recerca","ror":"https://ror.org/01d5vx451","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210102407","https://openalex.org/I4387153040"]}],"countries":["AU","ES"],"is_corresponding":false,"raw_author_name":"M. Ulldemolins","raw_affiliation_strings":["Burns, Trauma and Critical Care Research Centre, The University of Queensland, Brisbane, Australia","Centro de Investigaci\u00f3n Biom\u00e9dica En Red de Enfermedades Respiratorias (CIBERES), Barcelona, Spain","Critical Care Department, University Hospital Vall d'Hebron, Institut de Recerca Vall d'Hebron-Universitat Aut\u00f2noma de Barcelona, Barcelona, Spain and Institut d'Investigaci\u00f3 Sanit\u00e0ria pere Virgili (IISPV), Tarragona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Burns, Trauma and Critical Care Research Centre, The University of Queensland, Brisbane, Australia","institution_ids":["https://openalex.org/I165143802"]},{"raw_affiliation_string":"Centro de Investigaci\u00f3n Biom\u00e9dica En Red de Enfermedades Respiratorias (CIBERES), Barcelona, Spain","institution_ids":["https://openalex.org/I4210099160"]},{"raw_affiliation_string":"Critical Care Department, University Hospital Vall d'Hebron, Institut de Recerca Vall d'Hebron-Universitat Aut\u00f2noma de Barcelona, Barcelona, Spain and Institut d'Investigaci\u00f3 Sanit\u00e0ria pere Virgili (IISPV), Tarragona, Spain","institution_ids":["https://openalex.org/I123044942","https://openalex.org/I4210101772","https://openalex.org/I4210102407"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037468542","display_name":"Jason Alexander Roberts","orcid":"https://orcid.org/0000-0001-6218-435X","observed_orcids":["https://orcid.org/0000-0001-6218-435X"]},"institutions":[{"id":"https://openalex.org/I165143802","display_name":"The University of Queensland","ror":"https://ror.org/00rqy9422","country_code":"AU","type":"education","lineage":["https://openalex.org/I165143802"]},{"id":"https://openalex.org/I2799393793","display_name":"Royal Brisbane and Women's Hospital","ror":"https://ror.org/05p52kj31","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I1302211766","https://openalex.org/I2799393793","https://openalex.org/I2801244131"]}],"countries":["AU"],"is_corresponding":true,"raw_author_name":"J. A. Roberts","raw_affiliation_strings":["Burns, Trauma and Critical Care Research Centre, The University of Queensland, Brisbane, Australia","Department of Intensive Care Medicine, Royal Brisbane and Women's Hospital, Herston, Brisbane, Australia","Pharmacy Department, Royal Brisbane and Women's Hospital, Herston, Brisbane, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Burns, Trauma and Critical Care Research Centre, The University of Queensland, Brisbane, Australia","institution_ids":["https://openalex.org/I165143802"]},{"raw_affiliation_string":"Department of Intensive Care Medicine, Royal Brisbane and Women's Hospital, Herston, Brisbane, Australia","institution_ids":["https://openalex.org/I2799393793"]},{"raw_affiliation_string":"Pharmacy Department, Royal Brisbane and Women's Hospital, Herston, Brisbane, Australia","institution_ids":["https://openalex.org/I2799393793"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046635592","display_name":"Steven C. Wallis","orcid":"https://orcid.org/0000-0002-2392-9854","observed_orcids":["https://orcid.org/0000-0002-2392-9854"]},"institutions":[{"id":"https://openalex.org/I165143802","display_name":"The University of Queensland","ror":"https://ror.org/00rqy9422","country_code":"AU","type":"education","lineage":["https://openalex.org/I165143802"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"S. C. Wallis","raw_affiliation_strings":["Burns, Trauma and Critical Care Research Centre, The University of Queensland, Brisbane, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Burns, Trauma and Critical Care Research Centre, The University of Queensland, Brisbane, Australia","institution_ids":["https://openalex.org/I165143802"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042990512","display_name":"Jordi Rello","orcid":"https://orcid.org/0000-0003-0676-6210","observed_orcids":["https://orcid.org/0000-0003-0676-6210"]},"institutions":[{"id":"https://openalex.org/I123044942","display_name":"Universitat Aut\u00f2noma de Barcelona","ror":"https://ror.org/052g8jq94","country_code":"ES","type":"education","lineage":["https://openalex.org/I123044942"]},{"id":"https://openalex.org/I4210099160","display_name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Respiratorias","ror":"https://ror.org/0119pby33","country_code":"ES","type":"facility","lineage":["https://openalex.org/I2801357902","https://openalex.org/I4210099160","https://openalex.org/I4210115082","https://openalex.org/I4387152914"]},{"id":"https://openalex.org/I4210101772","display_name":"Institut de Recerca Biom\u00e8dica Catalunya Sud","ror":"https://ror.org/01av3a615","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210101772","https://openalex.org/I4387153040"]},{"id":"https://openalex.org/I4210102407","display_name":"Vall d'Hebron Institut de Recerca","ror":"https://ror.org/01d5vx451","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210102407","https://openalex.org/I4387153040"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"J. Rello","raw_affiliation_strings":["Centro de Investigaci\u00f3n Biom\u00e9dica En Red de Enfermedades Respiratorias (CIBERES), Barcelona, Spain","Critical Care Department, University Hospital Vall d'Hebron, Institut de Recerca Vall d'Hebron-Universitat Aut\u00f2noma de Barcelona, Barcelona, Spain and Institut d'Investigaci\u00f3 Sanit\u00e0ria pere Virgili (IISPV), Tarragona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centro de Investigaci\u00f3n Biom\u00e9dica En Red de Enfermedades Respiratorias (CIBERES), Barcelona, Spain","institution_ids":["https://openalex.org/I4210099160"]},{"raw_affiliation_string":"Critical Care Department, University Hospital Vall d'Hebron, Institut de Recerca Vall d'Hebron-Universitat Aut\u00f2noma de Barcelona, Barcelona, Spain and Institut d'Investigaci\u00f3 Sanit\u00e0ria pere Virgili (IISPV), Tarragona, Spain","institution_ids":["https://openalex.org/I123044942","https://openalex.org/I4210101772","https://openalex.org/I4210102407"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5066789024","display_name":"Jeffrey Lipman","orcid":"https://orcid.org/0000-0002-5965-9876","observed_orcids":["https://orcid.org/0000-0002-5965-9876"]},"institutions":[{"id":"https://openalex.org/I165143802","display_name":"The University of Queensland","ror":"https://ror.org/00rqy9422","country_code":"AU","type":"education","lineage":["https://openalex.org/I165143802"]},{"id":"https://openalex.org/I2799393793","display_name":"Royal Brisbane and Women's Hospital","ror":"https://ror.org/05p52kj31","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I1302211766","https://openalex.org/I2799393793","https://openalex.org/I2801244131"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"J. Lipman","raw_affiliation_strings":["Burns, Trauma and Critical Care Research Centre, The University of Queensland, Brisbane, Australia","Department of Intensive Care Medicine, Royal Brisbane and Women's Hospital, Herston, Brisbane, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Burns, Trauma and Critical Care Research Centre, The University of Queensland, Brisbane, Australia","institution_ids":["https://openalex.org/I165143802"]},{"raw_affiliation_string":"Department of Intensive Care Medicine, Royal Brisbane and Women's Hospital, Herston, Brisbane, Australia","institution_ids":["https://openalex.org/I2799393793"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5037468542"],"corresponding_institution_ids":["https://openalex.org/I165143802","https://openalex.org/I2799393793"],"apc_list":{"value":2869,"currency":"GBP","value_usd":3784},"apc_paid":null,"fwci":5.3792,"has_fulltext":false,"cited_by_count":125,"citation_normalized_percentile":{"value":0.95707248,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":95,"max":100},"biblio":{"volume":"65","issue":"8","first_page":"1771","last_page":"1778"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10195","display_name":"Antimicrobial Resistance in Staphylococcus","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10218","display_name":"Sepsis Diagnosis and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2706","display_name":"Critical Care and Intensive Care Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/flucloxacillin","display_name":"flucloxacillin","score":1.0},{"id":"https://openalex.org/keywords/hypoalbuminemia","display_name":"hypoalbuminemia","score":0.9919999837875366},{"id":"https://openalex.org/keywords/unbound-plasma-concentration","display_name":"unbound plasma concentration","score":0.796999990940094},{"id":"https://openalex.org/keywords/protein-binding","display_name":"protein binding","score":0.7889999747276306},{"id":"https://openalex.org/keywords/critically-ill-patients","display_name":"critically ill patients","score":0.8360000252723694},{"id":"https://openalex.org/keywords/population-pharmacokinetics","display_name":"population pharmacokinetics","score":0.7450000047683716},{"id":"https://openalex.org/keywords/continuous-infusion","display_name":"continuous infusion","score":0.6050000190734863},{"id":"https://openalex.org/keywords/intermittent-bolus-dosing","display_name":"intermittent bolus dosing","score":0.7839999794960022},{"id":"https://openalex.org/keywords/methicillin-susceptible-staphylococcus-aureus","display_name":"methicillin-susceptible Staphylococcus aureus","score":0.9430000185966492},{"id":"https://openalex.org/keywords/pharmacokinetic-pharmacodynamic-target-attainment","display_name":"pharmacokinetic/pharmacodynamic target attainment","score":0.8700000047683716},{"id":"https://openalex.org/keywords/dosing-regimen","display_name":"dosing regimen","score":0.6579999923706055}],"concepts":[{"id":"https://openalex.org/C2778355172","wikidata":"https://www.wikidata.org/wiki/Q1994556","display_name":"Flucloxacillin","level":4,"score":0.9481410980224609},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.7964081764221191},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.6661865711212158},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6305211782455444},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5929828882217407},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.5316149592399597},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.5090360045433044},{"id":"https://openalex.org/C2776239304","wikidata":"https://www.wikidata.org/wiki/Q6954915","display_name":"NONMEM","level":3,"score":0.44299039244651794},{"id":"https://openalex.org/C2779489039","wikidata":"https://www.wikidata.org/wiki/Q188121","display_name":"Staphylococcus aureus","level":3,"score":0.15254393219947815},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.060007721185684204},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0},{"id":"https://openalex.org/C523546767","wikidata":"https://www.wikidata.org/wiki/Q10876","display_name":"Bacteria","level":2,"score":0.0},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005436","descriptor_name":"Floxacillin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D005436","descriptor_name":"Floxacillin","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007262","descriptor_name":"Infusions, Intravenous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007275","descriptor_name":"Injections, Intravenous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008826","descriptor_name":"Microbial Sensitivity Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009010","descriptor_name":"Monte Carlo Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010949","descriptor_name":"Plasma","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014556","descriptor_name":"Urine","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D015233","descriptor_name":"Models, Statistical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016638","descriptor_name":"Critical Illness","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D034141","descriptor_name":"Hypoalbuminemia","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1093/jac/dkq184","doi":"https://doi.org/10.1093/jac/dkq184","is_oa":false,"landing_page_url":"https://doi.org/10.1093/jac/dkq184","pdf_url":null,"source":{"id":"https://openalex.org/S124275759","display_name":"Journal of Antimicrobial Chemotherapy","issn_l":"0305-7453","issn":["0305-7453","1460-2091"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Antimicrobial Chemotherapy","raw_type":"journal-article"},{"id":"pmid:20530507","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20530507","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of antimicrobial chemotherapy","raw_type":"Journal Article"},{"id":"pmh:oai:open-archive.highwire.org:jac:dkq184v1","doi":null,"is_oa":false,"landing_page_url":"http://jac.oxfordjournals.org/cgi/content/short/dkq184v1","pdf_url":null,"source":{"id":"https://openalex.org/S4406923041","display_name":"HighWire Press Open Archive","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"TEXT"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":34,"referenced_works":["https://openalex.org/W345054481","https://openalex.org/W1209613245","https://openalex.org/W1965789860","https://openalex.org/W1970762510","https://openalex.org/W1979922634","https://openalex.org/W2009720606","https://openalex.org/W2016702559","https://openalex.org/W2018386197","https://openalex.org/W2035849028","https://openalex.org/W2039740101","https://openalex.org/W2051367912","https://openalex.org/W2057226149","https://openalex.org/W2057650704","https://openalex.org/W2058796966","https://openalex.org/W2065470776","https://openalex.org/W2065624024","https://openalex.org/W2072296799","https://openalex.org/W2072945054","https://openalex.org/W2073122282","https://openalex.org/W2073728193","https://openalex.org/W2079691262","https://openalex.org/W2082321986","https://openalex.org/W2084904184","https://openalex.org/W2096139157","https://openalex.org/W2113717321","https://openalex.org/W2114903378","https://openalex.org/W2117553136","https://openalex.org/W2125129453","https://openalex.org/W2156273542","https://openalex.org/W2159122271","https://openalex.org/W2161446377","https://openalex.org/W2286608681","https://openalex.org/W2405887519","https://openalex.org/W2439297264"],"related_works":["https://openalex.org/W4323046723","https://openalex.org/W3197222359","https://openalex.org/W3028357818","https://openalex.org/W2901654988","https://openalex.org/W2808666959","https://openalex.org/W3155834301","https://openalex.org/W2096139157","https://openalex.org/W4310701930","https://openalex.org/W4400221779"],"abstract_inverted_index":{"OBJECTIVES:":[0],"To":[1],"describe":[2],"the":[3,40,135,138,149,178,236,242,252],"total":[4,100],"and":[5,23,28,34,56,70,76,85,222],"unbound":[6,68,82,256],"plasma":[7,69,83,101],"concentration-time":[8],"profiles":[9],"for":[10,99,148,191,235,258,262],"highly":[11,263],"protein-bound":[12],"flucloxacillin":[13,58,105,122,171],"(95%-97%":[14],"protein":[15],"binding)":[16],"in":[17,109,220],"critically":[18,110],"ill":[19,111],"patients":[20,53,112],"with":[21,54,92,113,117],"hypoalbuminaemia":[22,55,114],"without":[24],"severe":[25],"renal":[26],"dysfunction,":[27],"to":[29,38,218,231],"use":[30],"population":[31],"pharmacokinetic":[32,79,95],"modelling":[33,80],"Monte":[35,86,160],"Carlo":[36,87,161],"simulations":[37,88,162],"assess":[39],"probability":[41],"of":[42,61,81,137,151,167,177,198,210,225,238,247,254],"target":[43],"attainment":[44,176],"against":[45],"an":[46],"MIC":[47,190],"distribution.":[48],"PATIENTS":[49],"AND":[50],"METHODS:":[51],"Ten":[52],"receiving":[57],"as":[59],"part":[60],"therapy":[62],"were":[63,74,89],"enrolled.":[64],"Sixty-seven":[65],"total,":[66],"67":[67],"10":[71],"urine":[72],"samples":[73],"collected":[75],"analysed.":[77],"Population":[78],"data":[84,250],"then":[90],"undertaken":[91],"NONMEM.":[93],"Non-compartmental":[94],"analysis":[96],"was":[97,107],"performed":[98],"concentrations.":[102],"RESULTS:":[103],"Total":[104],"V":[106],"increased":[108],"2-fold":[115],"compared":[116],"healthy":[118],"volunteer":[119],"data.":[120],"Unbound":[121],"concentrations":[123,257],"after":[124,134],"2":[125,158],"g":[126],"bolus":[127,215],"fell":[128],"below":[129],"1":[130],"mg/L":[131],"4":[132],"h":[133,170],"end":[136],"infusion,":[139],"providing":[140],"evidence":[141],"that":[142,164],"standard":[143,211],"dosing":[144],"would":[145,172,205],"be":[146,206],"insufficient":[147],"treatment":[150,237],"methicillin-susceptible":[152],"Staphylococcus":[153],"aureus":[154],"(MSSA)":[155],"(MIC":[156],"=":[157],"mg/L).":[159],"suggest":[163],"continuous":[165,196,223],"infusion":[166,197,224],"8":[168],"g/24":[169,203],"enable":[173],"100%":[174,192],"successful":[175],"pharmacodynamic":[179],"target,":[180],"50%":[181],"fT(":[182,193],">":[183,194],"MIC).":[184],"For":[185],"more":[186,229],"aggressive":[187],"targets":[188,234],"(4-5x":[189],"MIC)),":[195],"higher":[199,226],"doses":[200,212,227],"(i.e.":[201],"12":[202],"h)":[204],"required.":[207],"CONCLUSIONS:":[208],"Administration":[209],"by":[213,241],"intermittent":[214],"is":[216,228],"likely":[217,230],"result":[219],"underdosing,":[221],"achieve":[232],"pharmacokinetic-pharmacodynamic":[233],"infections":[239],"caused":[240],"most":[243],"common":[244],"wild":[245],"type":[246],"MSSA.":[248],"Our":[249],"emphasize":[251],"importance":[253],"using":[255],"determining":[259],"dosage":[260],"regimens":[261],"bound":[264],"antibiotics.":[265]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2165705156","counts_by_year":[{"year":2026,"cited_by_count":6},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":7},{"year":2023,"cited_by_count":12},{"year":2022,"cited_by_count":7},{"year":2021,"cited_by_count":9},{"year":2020,"cited_by_count":9},{"year":2019,"cited_by_count":9},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":7},{"year":2014,"cited_by_count":16},{"year":2013,"cited_by_count":5},{"year":2012,"cited_by_count":10}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2016-06-24T00:00:00"}
